{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:28:04Z","timestamp":1763141284370,"version":"3.37.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T00:00:00Z","timestamp":1579046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Institute for Safety, Compensation and Recovery Research","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychol Rev"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11065-020-09427-7","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T20:02:22Z","timestamp":1579118542000},"page":"28-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1152-0576","authenticated-orcid":false,"given":"Amelia J.","family":"Hicks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona J.","family":"Clay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie L.","family":"Ponsford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke A.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahesh","family":"Jayaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Batty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,15]]},"reference":[{"issue":"1","key":"9427_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2559.1989.tb03040.x","volume":"15","author":"JH Adams","year":"1989","unstructured":"Adams, J. H., Doyle, D., Ford, I., Gennarelli, T., Graham, D., & McLellan, D. (1989). Diffuse axonal injury in head injury: Definition, diagnosis and grading. Histopathology, 15(1), 49\u201359.","journal-title":"Histopathology"},{"key":"9427_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/TCRM.S53906","volume":"9","author":"A Ahmed","year":"2013","unstructured":"Ahmed, A., & Simmons, Z. (2013). Pseudobulbar affect: prevalence and management. Therapeutics and Clinical Risk Management, 9, 483\u2013489. https:\/\/doi.org\/10.2147\/TCRM.S53906","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"780","key":"9427_CR3","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/pgmj.66.780.818","volume":"66","author":"P Allman","year":"1990","unstructured":"Allman, P., Hope, R. A., & Fairburn, C. G. (1990). Emotionalism following brain damage: A complex phenomenon. Postgraduate Medical Journal, 66(780), 818\u2013821.","journal-title":"Postgraduate Medical Journal"},{"issue":"1","key":"9427_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","volume":"58","author":"IM Anderson","year":"2000","unstructured":"Anderson, I. M. (2000). Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. Journal of Affective Disorders, 58(1), 19\u201336.","journal-title":"Journal of Affective Disorders"},{"issue":"S5","key":"9427_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s1092852900026602","volume":"10","author":"DB Arciniegas","year":"2014","unstructured":"Arciniegas, D. B., Lauterbach, E. C., Ginsberg, D. L., Anderson, K. E., Chow, T. W., Flashman, L. A., et al. (2014). The differential diagnosis of Pseudobulbar affect (PBA): Distinguishing PBA among disorders of mood and affect. CNS Spectrums, 10(S5), 1\u201316. https:\/\/doi.org\/10.1017\/s1092852900026602","journal-title":"CNS Spectrums"},{"issue":"1","key":"9427_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.psc.2013.12.001","volume":"37","author":"DB Arciniegas","year":"2014","unstructured":"Arciniegas, D. B., & Wortzel, H. S. (2014). Emotional and behavioral dyscontrol after traumatic brain injury. Psychiatric Clinics of North America, 37(1), 31\u201353. https:\/\/doi.org\/10.1016\/j.psc.2013.12.001","journal-title":"Psychiatric Clinics of North America"},{"issue":"1","key":"9427_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jrsm.1127","volume":"6","author":"KM Atkinson","year":"2015","unstructured":"Atkinson, K. M., Koenka, A. C., Sanchez, C. E., Moshontz, H., & Cooper, H. (2015). Reporting standards for literature searches and report inclusion criteria: Making research syntheses more transparent and easy to replicate. Research Synthesis Methods, 6(1), 87\u201395. https:\/\/doi.org\/10.1002\/jrsm.1127","journal-title":"Research Synthesis Methods"},{"issue":"4","key":"9427_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001419","volume":"10","author":"EM Beller","year":"2013","unstructured":"Beller, E. M., Glasziou, P. P., Altman, D. G., Hopewell, S., Bastian, H., Chalmers, I., \u2026 PRISMA for Abstracts Group. (2013). PRISMA for abstracts: Reporting systematic reviews in journal and conference abstracts. PLoS Medicine, 10(4), e1001419. https:\/\/doi.org\/10.1371\/journal.pmed.1001419","journal-title":"PLoS Medicine"},{"issue":"4","key":"9427_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/02699050410001720121","volume":"19","author":"TP Beresford","year":"2005","unstructured":"Beresford, T. P., Arciniegas, D., Clapp, L., Martin, B., & Alfers, J. (2005). Reduction of affective lability and alcohol use following traumatic brain injury: A clinical pilot study of anti-convulsant medications. Brain Injury, 19(4), 309\u2013313. https:\/\/doi.org\/10.1080\/02699050410001720121","journal-title":"Brain Injury"},{"issue":"8","key":"9427_CR10","doi-asserted-by":"publisher","first-page":"e72232","DOI":"10.1371\/journal.pone.0072232","volume":"8","author":"BR Brooks","year":"2013","unstructured":"Brooks, B. R., Crumpacker, D., Fellus, J., Kantor, D., & Kaye, R. E. (2013). PRISM: A novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS One, 8(8), e72232. https:\/\/doi.org\/10.1371\/journal.pone.0072232","journal-title":"PLoS One"},{"issue":"8","key":"9427_CR11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","volume":"63","author":"BR Brooks","year":"2004","unstructured":"Brooks, B. R., Thisted, R. A., Appel, S. H., Bradley, W. G., Olney, R. K., Berg, J. E., \u2026 AVP-923 ALS Study Group. (2004). Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: A randomized trial. Neurology, 63(8), 1364\u20131370. https:\/\/doi.org\/10.1212\/01.WNL.0000142042.50528.2F","journal-title":"Neurology"},{"issue":"3","key":"9427_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.yebeh.2006.01.017","volume":"8","author":"LM Chahine","year":"2006","unstructured":"Chahine, L. M., & Chemali, Z. (2006). Du rire aux larmes: Pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine. Epilepsy & Behavior, 8(3), 610\u2013615. https:\/\/doi.org\/10.1016\/j.yebeh.2006.01.017","journal-title":"Epilepsy & Behavior"},{"issue":"18 Suppl","key":"9427_CR13","first-page":"S345","volume":"23","author":"JJ Chen","year":"2017","unstructured":"Chen, J. J. (2017). Pharmacotherapeutic management of pseudobulbar affect. American Journal of Managed Care, 23(18 Suppl), S345\u2013S350.","journal-title":"American Journal of Managed Care"},{"key":"9427_CR14","doi-asserted-by":"crossref","unstructured":"Clay, F., Hicks, A. J., Perry, L. J., Ponsford, J. L., Jayaram, M., & Hopwood, M. (2018). Pharmacotherapy for the pseudobulbar affect in individuals who have sustained a traumatic brain injury: A systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 9 In Press.","DOI":"10.11124\/JBISRIR-2017-003648"},{"issue":"9","key":"9427_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12325-012-0043-7","volume":"29","author":"J Colamonico","year":"2012","unstructured":"Colamonico, J., Formella, A., & Bradley, W. (2012). Pseudobulbar affect: Burden of illness in the USA. Advances in Therapy, 29(9), 775\u2013798. https:\/\/doi.org\/10.1007\/s12325-012-0043-7","journal-title":"Advances in Therapy"},{"issue":"6","key":"9427_CR16","first-page":"325","volume":"38","author":"MP Cruz","year":"2013","unstructured":"Cruz, M. P. (2013). Nuedexta for the treatment of pseudobulbar affect: A condition of involuntary crying or laughing. P T, 38(6), 325\u2013328.","journal-title":"P T"},{"issue":"S6","key":"9427_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s1092852900026614","volume":"11","author":"JL Cummings","year":"2014","unstructured":"Cummings, J. L., Arciniegas, D. B., Brooks, B. R., Herndon, R. M., Lauterbach, E. C., Pioro, E. P., et al. (2014). Defining and diagnosing involuntary emotional expression disorder. CNS Spectrums, 11(S6), 1\u201311. https:\/\/doi.org\/10.1017\/s1092852900026614","journal-title":"CNS Spectrums"},{"issue":"2","key":"9427_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.17925\/ENR.2013.08.02.74","volume":"8","author":"J Cummings","year":"2013","unstructured":"Cummings, J., Gilbart, J., & Andersen, G. (2013). Pseudobulbar affect. A disabling but under-recognized consequence of neurological disease and brain injury. European Neurological Review, 8(2), 74\u201381.","journal-title":"European Neurological Review"},{"issue":"S5","key":"9427_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1017\/s1092852900025955","volume":"12","author":"JE Duda","year":"2014","unstructured":"Duda, J. E. (2014). History and prevalence of involuntary emotional expression disorder. CNS Spectrums, 12(S5), 6\u201310. https:\/\/doi.org\/10.1017\/s1092852900025955","journal-title":"CNS Spectrums"},{"issue":"4","key":"9427_CR20","first-page":"253","volume":"4","author":"J Fellus","year":"2014","unstructured":"Fellus, J., DeFina, P., Carson, C., Machado, C., & Chinchilla, M. (2014). Dextromethorphan\/quinidine alleviates pseudobulbar affect and rapidly eliminates suicidal ideation in individuals with traumatic brain injury. Functional Neurology, Rehabilitation, and Ergonomics, 4(4), 253.","journal-title":"Functional Neurology, Rehabilitation, and Ergonomics"},{"issue":"7","key":"9427_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1682\/JRRD.2014.08.0191","volume":"52","author":"JR Fonda","year":"2015","unstructured":"Fonda, J. R., Hunt, P. R., McGlinchey, R. E., Rudolph, J. L., Milberg, W. P., Reynolds, M. W., et al. (2015). Identification of pseudobulbar affect symptoms in veterans with possible traumatic brain injury. Journal of Rehabilitation Research and Development, 52(7), 839\u2013849. https:\/\/doi.org\/10.1682\/JRRD.2014.08.0191","journal-title":"Journal of Rehabilitation Research and Development"},{"issue":"12","key":"9427_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002886","volume":"95","author":"D Garcia-Baran","year":"2016","unstructured":"Garcia-Baran, D., Johnson, T. M., Wagner, J., Shen, J., & Geers, M. (2016). Therapeutic approach of a high functioning individual with traumatic brain injury and subsequent emotional volatility with features of pathological laughter and crying with dextromethorphan\/quinidine. Medicine (Baltimore), 95(12), e2886. https:\/\/doi.org\/10.1097\/MD.0000000000002886","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"9427_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/107385849800400316","volume":"4","author":"TA Gennarelli","year":"1998","unstructured":"Gennarelli, T. A., Thibault, L. E., & Graham, D. I. (1998). Diffuse axonal injury: An important form of traumatic brain damage. The Neuroscientist, 4(3), 202\u2013215.","journal-title":"The Neuroscientist"},{"issue":"1","key":"9427_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12883-016-0609-0","volume":"16","author":"FM Hammond","year":"2016","unstructured":"Hammond, F. M., Alexander, D. N., Cutler, A. J., D\u2019Amico, S., Doody, R. S., Sauve, W., et al. (2016). PRISM II: An open-label study to assess effectiveness of dextromethorphan\/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology, 16(1), 89.","journal-title":"BMC Neurology"},{"key":"9427_CR25","doi-asserted-by":"crossref","unstructured":"Hammond, F. M., Sauve, W., Ledon, F., Davis, C., & Formella, A. E. (2018). Safety, tolerability, and effectiveness of dextromethorphan\/quinidine for Pseudobulbar affect among study participants with traumatic brain injury: Results from the PRISM-II open label study. PM&R.","DOI":"10.1016\/j.pmrj.2018.02.010"},{"issue":"2","key":"9427_CR26","doi-asserted-by":"publisher","first-page":"11A","DOI":"10.1002\/ana.21100","volume":"61","author":"SC Johnston","year":"2007","unstructured":"Johnston, S. C., & Hauser, S. L. (2007). Marketing and drug costs: Who is laughing and crying? Annals of Neurology, 61(2), 11A\u201312A. https:\/\/doi.org\/10.1002\/ana.21100","journal-title":"Annals of Neurology"},{"issue":"520","key":"9427_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1192\/bjp.115.520.281","volume":"115","author":"IR Lawson","year":"1969","unstructured":"Lawson, I. R., & MacLoed, R. D. (1969). The use of imipramine (\" Tofranil\") and other psychotropic drugs in organic emotionalism. The British Journal of Psychiatry, 115(520), 281\u2013285.","journal-title":"The British Journal of Psychiatry"},{"issue":"7","key":"9427_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., G\u00f8tzsche, P. C., Ioannidis, J. P., \u2026 Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6(7), e1000100.","journal-title":"PLoS Medicine"},{"issue":"1\u20132","key":"9427_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0165-0173(01)00083-2","volume":"38","author":"EH Lo","year":"2001","unstructured":"Lo, E. H., Singhal, A. B., Torchilin, V. P., & Abbott, N. J. (2001). Drug delivery to damaged brain. Brain Research. Brain Research Reviews, 38(1\u20132), 140\u2013148. https:\/\/doi.org\/10.1016\/S0165-0173(01)00083-2","journal-title":"Brain Research. Brain Research Reviews"},{"issue":"7","key":"9427_CR30","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1586\/ern.11.68","volume":"11","author":"A Miller","year":"2011","unstructured":"Miller, A., Pratt, H., & Schiffer, R. B. (2011). Pseudobulbar affect: The spectrum of clinical presentations, etiologies and treatments. Expert Review of Neurotherapeutics, 11(7), 1077\u20131088. https:\/\/doi.org\/10.1586\/ern.11.68","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"4","key":"9427_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher, D. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"9427_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jnnp.63.1.89","volume":"63","author":"SR Moore","year":"1997","unstructured":"Moore, S. R., Gresham, L. S., Bromberg, M. B., Kasarkis, E. J., & Smith, R. A. (1997). A self report measure of affective lability. Journal of Neurology, Neurosurgery and Psychiatry, 63(1), 89\u201393.","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"10","key":"9427_CR33","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/026990599121197","volume":"13","author":"U Muller","year":"1999","unstructured":"Muller, U., Murai, T., Bauer-Wittmund, T., & von Cramon, D. Y. (1999). Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Injury, 13(10), 805\u2013811.","journal-title":"Brain Injury"},{"issue":"5","key":"9427_CR34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.20828","volume":"59","author":"HS Panitch","year":"2006","unstructured":"Panitch, H. S., Thisted, R. A., Smith, R. A., Wynn, D. R., Wymer, J. P., Achiron, A., \u2026 Psuedobulbar Affect in Multiple Sclerosis Study Group. (2006). Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis. Annals of Neurology, 59(5), 780\u2013787. https:\/\/doi.org\/10.1002\/ana.20828","journal-title":"Annals of Neurology"},{"issue":"6","key":"9427_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s003300050496","volume":"8","author":"P Parizel","year":"1998","unstructured":"Parizel, P., \u00d6zsarlak, \u00d6., Van Goethem, J., Van Den Hauwe, L., Dillen, C., Verlooy, J., et al. (1998). Imaging findings in diffuse axonal injury after closed head trauma. European Radiology, 8(6), 960\u2013965.","journal-title":"European Radiology"},{"issue":"9","key":"9427_CR36","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/brain\/124.9.1708","volume":"124","author":"J Parvizi","year":"2001","unstructured":"Parvizi, J. (2001). Pathological laughter and crying: A link to the cerebellum. Brain, 124(9), 1708\u20131719. https:\/\/doi.org\/10.1093\/brain\/124.9.1708","journal-title":"Brain"},{"issue":"11","key":"9427_CR37","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.4065\/81.11.1482","volume":"81","author":"J Parvizi","year":"2006","unstructured":"Parvizi, J., Arciniegas, D. B., Bernardini, G. L., Hoffmann, M. W., Mohr, J. P., Rapoport, M. J., \u2026 Tuhrim, S. (2006). Diagnosis and management of pathological laughter and crying. Mayo Clinic Proceedings, 81(11), 1482\u20131486. https:\/\/doi.org\/10.4065\/81.11.1482","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"9427_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1176\/appi.neuropsych.21.1.75","volume":"21","author":"J Parvizi","year":"2009","unstructured":"Parvizi, J., Coburn, K. L., Shillcutt, S. D., Coffey, C. E., Lauterbach, E. C., & Mendez, M. F. (2009). Neuroanatomy of pathological laughing and crying: A report of the American neuropsychiatric association committee on research. Journal of Neuropsychiatry and Clinical Neurosciences, 21(1), 75\u201387. https:\/\/doi.org\/10.1176\/appi.neuropsych.21.1.75","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"11","key":"9427_CR39","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1185\/03007995.2014.940040","volume":"30","author":"GL Pattee","year":"2014","unstructured":"Pattee, G. L., Wymer, J. P., Lomen-Hoerth, C., Appel, S. H., Formella, A. E., & Pope, L. E. (2014). An open-label multicenter study to assess the safety of dextromethorphan\/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions. Current Medical Research and Opinion, 30(11), 2255\u20132265. https:\/\/doi.org\/10.1185\/03007995.2014.940040","journal-title":"Current Medical Research and Opinion"},{"issue":"9","key":"9427_CR40","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2165\/11591450-000000000-00000","volume":"71","author":"EP Pioro","year":"2011","unstructured":"Pioro, E. P. (2011). Current concepts in the pharmacotherapy of pseudobulbar affect. Drugs, 71(9), 1193\u20131207. https:\/\/doi.org\/10.2165\/11591450-000000000-00000","journal-title":"Drugs"},{"issue":"5","key":"9427_CR41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/ana.22093","volume":"68","author":"EP Pioro","year":"2010","unstructured":"Pioro, E. P., Brooks, B. R., Cummings, J., Schiffer, R., Thisted, R. A., Wynn, D., \u2026 Efficacy Results Trial of AVP-923 in PBA Investigators. (2010). Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Annals of Neurology, 68(5), 693\u2013702. https:\/\/doi.org\/10.1002\/ana.22093","journal-title":"Annals of Neurology"},{"issue":"1","key":"9427_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.rehab.2015.10.003","volume":"59","author":"D Plantier","year":"2016","unstructured":"Plantier, D., Luaute, J., & Group, S. (2016). Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice. Annals of Physical and Rehabilitation Medicine, 59(1), 42\u201357. https:\/\/doi.org\/10.1016\/j.rehab.2015.10.003","journal-title":"Annals of Physical and Rehabilitation Medicine"},{"issue":"3","key":"9427_CR43","first-page":"184","volume":"19","author":"P Presecki","year":"2007","unstructured":"Presecki, P., & Mimica, N. (2007). Involuntary emotional expression disorder - new\/old disease in psychiatry and neurology. Psychiatria Danubina, 19(3), 184\u2013188.","journal-title":"Psychiatria Danubina"},{"issue":"4 Suppl 5","key":"9427_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/S1092852900025979","volume":"12","author":"PV Rabins","year":"2007","unstructured":"Rabins, P. V., & Arciniegas, D. B. (2007). Pathophysiology of involuntary emotional expression disorder. CNS Spectrums, 12(4 Suppl 5), 17\u201322.","journal-title":"CNS Spectrums"},{"issue":"2","key":"9427_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1176\/ajp.150.2.286","volume":"150","author":"RG Robinson","year":"1993","unstructured":"Robinson, R. G., Parikh, R. M., Lipsey, J. R., Starkstein, S. E., & Price, T. R. (1993). Pathological laughing and crying following stroke: Validation of a measurement scale and a double-blind treatment study. American Journal of Psychiatry, 150(2), 286\u2013293. https:\/\/doi.org\/10.1176\/ajp.150.2.286","journal-title":"American Journal of Psychiatry"},{"key":"9427_CR46","doi-asserted-by":"crossref","unstructured":"Robinson-Smith, G., & Grill, J. D. (2007, 2007\/08\/\/). Recognizing involuntary emotional expression disorder. [disease\/disorder overview]. Journal of Neuroscience Nursing, p. 202+.","DOI":"10.1097\/01376517-200708000-00003"},{"issue":"9","key":"9427_CR47","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1358\/dot.2008.44.9.1258664","volume":"44","author":"H Rosen","year":"2008","unstructured":"Rosen, H. (2008). Dextromethorphan\/quinidine sulfate for pseudobulbar affect. Drugs Today (Barc), 44(9), 661\u2013668. https:\/\/doi.org\/10.1358\/dot.2008.44.9.1258664","journal-title":"Drugs Today (Barc)"},{"issue":"4","key":"9427_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1176\/appi.neuropsych.15030045","volume":"27","author":"D Roy","year":"2015","unstructured":"Roy, D., McCann, U., Han, D., & Rao, V. (2015). Pathological laughter and crying and psychiatric comorbidity after traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 27(4), 299\u2013303. https:\/\/doi.org\/10.1176\/appi.neuropsych.15030045","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"9427_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jad.2015.10.003","volume":"190","author":"JL Rudolph","year":"2016","unstructured":"Rudolph, J. L., Fonda, J. R., Hunt, P. R., McGlinchey, R. E., Milberg, W. P., Reynolds, M. W., et al. (2016). Association of Pseudobulbar Affect symptoms with quality of life and healthcare costs in veterans with traumatic brain injury. Journal of Affective Disorders, 190, 150\u2013155. https:\/\/doi.org\/10.1016\/j.jad.2015.10.003","journal-title":"Journal of Affective Disorders"},{"issue":"S1","key":"9427_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1017\/S1092852916000791","volume":"21","author":"WM Sauve","year":"2016","unstructured":"Sauve, W. M. (2016). Recognizing and treating pseudobulbar affect. CNS Spectrums, 21(S1), 34\u201344. https:\/\/doi.org\/10.1017\/S1092852916000791","journal-title":"CNS Spectrums"},{"issue":"4","key":"9427_CR51","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1176\/jnp.17.4.447","volume":"17","author":"R Schiffer","year":"2005","unstructured":"Schiffer, R., & Pope, L. E. (2005). Review of pseudobulbar affect including a novel and potential therapy. Journal of Neuropsychiatry and Clinical Neurosciences, 17(4), 447\u2013454. https:\/\/doi.org\/10.1176\/jnp.17.4.447","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"9427_CR52","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2147\/NDT.S30713","volume":"10","author":"KA Schoedel","year":"2014","unstructured":"Schoedel, K. A., Morrow, S. A., & Sellers, E. M. (2014). Evaluating the safety and efficacy of dextromethorphan\/quinidine in the treatment of pseudobulbar affect. Neuropsychiatric Disease and Treatment, 10, 1161\u20131174. https:\/\/doi.org\/10.2147\/NDT.S30713","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"9427_CR53","doi-asserted-by":"crossref","unstructured":"Sloan, R., Brown, K., & Pentland, B. (1992). Fluoxetine as a treatment for emotional lability after brain injury. Brain Injury 6(4): 315\u2013319","DOI":"10.3109\/02699059209034945"},{"issue":"4","key":"9427_CR54","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1176\/jnp.16.4.426","volume":"16","author":"A Tateno","year":"2004","unstructured":"Tateno, A., Jorge, R. E., & Robinson, R. G. (2004). Pathological laughing and crying following traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 16(4), 426\u2013434. https:\/\/doi.org\/10.1176\/jnp.16.4.426","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"9427_CR55","unstructured":"Team, N. D. R. (2010). Risk assessment and risk mitigation review - 021879Orig1s000. In D. o. H. a. H. services (Ed.): Food and Drug Administration; Centre for Drug Evaluation Research"},{"key":"9427_CR56","unstructured":"The Joanna Briggs Institute. (2014). Joanna Briggs institute reviewers\u2019 manual (2014th ed.). Australia: The Joanna Briggs Institute."},{"key":"9427_CR57","unstructured":"Traumatic Brain Injury Medical Treatment Guidelines (2012). In D. O. W. C. Department of Labor and Employment (Ed.). State of Colorado."},{"issue":"3","key":"9427_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1191\/0269215502cr489oa","volume":"16","author":"L Turner-Stokes","year":"2002","unstructured":"Turner-Stokes, L., Hassan, N., Pierce, K., & Clegg, F. (2002). Managing depression in brain injury rehabilitation: The use of an integrated care pathway and preliminary report of response to sertraline. Clinical Rehabilitation, 16(3), 261\u2013268. https:\/\/doi.org\/10.1191\/0269215502cr489oa","journal-title":"Clinical Rehabilitation"},{"issue":"2","key":"9427_CR59","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.expneurol.2007.06.013","volume":"207","author":"LL Werling","year":"2007","unstructured":"Werling, L. L., Keller, A., Frank, J. G., & Nuwayhid, S. J. (2007). A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder. Experimental Neurology, 207(2), 248\u2013257. https:\/\/doi.org\/10.1016\/j.expneurol.2007.06.013","journal-title":"Experimental Neurology"},{"key":"9427_CR60","unstructured":"Willyerd, F. A., Empey, P. E., Kochanek, P. M., & Clark, R. S. (2014). Barriers to drug delivery for brain trauma. In Vascular Mechanisms in CNS Trauma (pp. 125-140): Springer."},{"issue":"7","key":"9427_CR61","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s12325-011-0031-3","volume":"28","author":"SS Work","year":"2011","unstructured":"Work, S. S., Colamonico, J. A., Bradley, W. G., & Kaye, R. E. (2011). Pseudobulbar affect: An under-recognized and under-treated neurological disorder. Advances in Therapy, 28(7), 586\u2013601. https:\/\/doi.org\/10.1007\/s12325-011-0031-3","journal-title":"Advances in Therapy"},{"issue":"7","key":"9427_CR62","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2165\/00023210-200822070-00001","volume":"22","author":"HS Wortzel","year":"2008","unstructured":"Wortzel, H. S., Oster, T. J., Anderson, C. A., & Arciniegas, D. B. (2008). Pathological laughing and crying : Epidemiology, pathophysiology and treatment. CNS Drugs, 22(7), 531\u2013545.","journal-title":"CNS Drugs"},{"issue":"1","key":"9427_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40265-014-0328-z","volume":"75","author":"LPH Yang","year":"2015","unstructured":"Yang, L. P. H., & Deeks, E. D. (2015). Dextromethorphan\/quinidine: A review of its use in adults with Pseudobulbar affect. Drugs, 75(1), 83\u201390. https:\/\/doi.org\/10.1007\/s40265-014-0328-z","journal-title":"Drugs"}],"container-title":["Neuropsychology Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11065-020-09427-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11065-020-09427-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11065-020-09427-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T07:38:32Z","timestamp":1610609912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11065-020-09427-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,15]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9427"],"URL":"https:\/\/doi.org\/10.1007\/s11065-020-09427-7","relation":{},"ISSN":["1040-7308","1573-6660"],"issn-type":[{"type":"print","value":"1040-7308"},{"type":"electronic","value":"1573-6660"}],"subject":[],"published":{"date-parts":[[2020,1,15]]},"assertion":[{"value":"18 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"One of the chief investigators (MH) has given talks on this topic for which travel and accommodation has been paid by the organizers. In addition, he has accepted fees for consulting and research from the pharmaceutical companies Bionomics, Eli Lilly, Janssen-Cilag, Lundbeck, Novartis, Pfizer, Praxisand Servier. Lundbeck. All other authors declare no known competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}